Abhishek Roy, Lei Hao, Jamie Francisco, Jin Guan, Satvik Mareedu, Peiyong Zhai, Joseph Dodd-O, Corey Heffernan, Dominic Del Re, Eun Jung A Lee and 1 more
Article in Biomacromolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Abhishek RoyDepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States.ORCID 0009-0005-9927-2544
Lei HaoDepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States.
Jamie FranciscoDepartment of Cell Biology and Molecular Medicine, New Jersey Medical School, Newark, New Jersey 07103, United States.
Jin GuanDepartment of Cell Biology and Molecular Medicine, New Jersey Medical School, Newark, New Jersey 07103, United States.
Satvik MareeduDepartment of Cell Biology and Molecular Medicine, New Jersey Medical School, Newark, New Jersey 07103, United States.
Peiyong ZhaiDepartment of Cell Biology and Molecular Medicine, New Jersey Medical School, Newark, New Jersey 07103, United States.
Joseph Dodd-ODepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States.
Corey HeffernanDepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States.ORCID 0000-0001-8524-1169
Dominic Del ReDepartment of Cell Biology and Molecular Medicine, New Jersey Medical School, Newark, New Jersey 07103, United States.
Eun Jung A LeeDepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States.
Vivek A KumarDepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States.ORCID 0000-0001-7536-9281
Funding
New Jersey Alliance for Clinical Translational Science: NJ ACTSUL1TR003017 · NCATS · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI PANETTIERI, REYNOLD ALEXANDER · 2019 to 2023
$28.9M
Bioactive Scaffold for TMJ Disc Regeneration by Endogenous Stem/Progenitor CellsR01DE029321 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LEE, CHANG HUN · 2020 to 2024
$3.5M
Diversity Supplement for Angiogenic and anti-microbial supports for pulp regenerationR01DE031812 · NIDCR · UNIVERSITY OF HOUSTON · PI Vivek Kumar · 2022 to 2026
$3.3M
The role of Neurofibromin 2 in heart failureR01HL157483 · NHLBI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Dominic P Del Re · 2022 to 2026
$2.9M
The role of NF2 in myocardial ischemia and reperfusion injuryR01HL127339 · NHLBI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI DEL RE, DOMINIC P · 2015 to 2019
$2.0M
Treatment and Mechanisms of Diabetic Fracture HealingR01AR080895 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI DANA T GRAVES, Shuying Yang · 2023 to 2026
$2.0M
Peptide hydrogels for management and treatment of neovascular posterior segment diseasesR15EY029504 · NEI · NEW JERSEY INSTITUTE OF TECHNOLOGY · PI KUMAR, VIVEK · 2019 to 2020
$508k
Acellular composite hydrogel scaffolds for volumetric muscle regenerationR21AR079708 · NIAMS · NEW JERSEY INSTITUTE OF TECHNOLOGY · PI GRASMAN, JONATHAN M., KUMAR, VIVEK · 2022 to 2023
Myocardial infarction (MI) is a major cause of morbidity and mortality worldwide, especially in aging and metabolically unhealthy populations. A major target of regenerative tissue engineering is the restoration of viable cardiomyocytes to preserve cardiac function and circumvent the progression to heart failure post-MI. Amelioration of ischemia is a crucial component of such restorative strategies. Angiogenic β-sheet peptides can self-assemble into thixotropic nanofibrous hydrogels. These syringe aspiratable cytocompatible gels were loaded with stem cells and showed excellent cytocompatibility and minimal impact on the storage and loss moduli of hydrogels. Gels with and without cells were delivered into the myocardium of a mouse MI model (LAD ligation). Cardiac function and tissue remodeling were evaluated up to 4 weeks
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Injectable Peptide Hydrogels Loaded with Murine Embryonic Stem Cells Relieve Ischemia · full record | OpenQuestion